NPM1 and acute myeloid leukemia: In the absence of a fusion transcript or a NPM1 mutation, new approaches by digital PCR and next-generation sequencing (NGS) are being developed to evaluate the evolution of the various somatic mutations present at AML diagnosis [62,63].